Back to NRIX

Trails Edge Capital Partners, LP → NRIX

Trails Edge Capital Partners, LP NRIX Position History

Nurix Therapeutics, Inc.

Quarters held
4
Latest value
$37.3M
Q3 2026
Peak value
$38.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$33.1M
Q1 2026$27M
Q2 2026$38.2M
Q3 2026$37.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$37.3M1.57M——
Q2 2026$38.2M1.57M——
Q1 2026$27M1.74M——
Q4 2025$33.1M1.74M——

Other funds holding NRIX

Other Trails Edge Capital Partners, LP positions

LBRX

LB PHARMACEUTICALS INC

$49.4M
LBRX

LB PHARMACEUTICALS INC

$44.1M
BMRN

BIOMARIN PHARMACEUTICAL INC

$40M
PCVX

VAXCYTE INC

$38.5M
ACAD

ACADIA PHARMACEUTICALS INC

$37.9M
OBX

OBSIDIAN THERAPEUTICS INC

$34.3M
PCVX

VAXCYTE INC

$34M
IMCR

IMMUNOCORE HLDGS PLC

$33.8M